-
May 22, 2012
Anshika Jha will be based in the British High Commission in New Delhi and work with representatives from UK Trade and Investment and the Foreign Office to help British businesses operating in India
-
May 07, 2012
German pharmaceutical company Bayer has appealed a decision by India’s Controller of Patents to grant a compulsory license over its cancer treatment drug sorafenib
-
April 26, 2012
The Asia-Pacific region is the first to celebrate World IP Day. Peter Leung in Hong Kong rounds up some of the activities
-
April 23, 2012
Foreign patent owners have nothing to fear from the Indian patent system, a local lawyer told IP owners last week
-
March 19, 2012
A senior figure within India’s generic drugs industry says that more domestic companies are waiting to file applications for compulsory licences over patented pharmaceuticals
-
March 15, 2012
Hogan Lovells won the inaugural global IP firm of the year award at tonight’s Managing IP Awards Dinner in London
-
March 12, 2012
Today India has granted its first compulsory licence over a drug. But what of other countries that have used the IP system to make it easier for patients to access medicines?
-
March 12, 2012
In one of his final tasks before leaving the job, the outgoing head of India’s patent office has issued the country’s first compulsory licence over a drug since India began protecting pharmaceutical products seven years ago
-
March 12, 2012
India’s Controller of Patents has issued a compulsory licence over a cancer-treating drug, sorafenib, whose patent is held by Bayer
-
March 09, 2012
Patent owners in India that want to enforce their rights in the courts have to deal with a series of obstacles. Pharmaceutical patents involve extra hurdles
-
March 09, 2012
Patent practitioners revealed a series of issues with India’s complex prosecution system at Managing IP’s India IP and Innovation Forum last week
-
February 28, 2012
The head of India’s IP Office, PH Kurian, is to step down in less than a fortnight and will be succeeded by Chaitanya Prasad
-
February 13, 2012
The latest round of negotations between the EU and India over a free-trade agreement was disrupted by protests over the way the IP clauses in the deal could affect access to medicines in developing countries
-
February 01, 2012
New firms are emerging, and Mumbai is catching up with Delhi, in the highly competitive Indian patent market
-
January 27, 2012
Free access: The nominations for Managing IP’s Global Awards 2012 have been announced
-
January 18, 2012
More patents than ever were filed at the EPO last year, but the upward trend masks the shifting fortunes of developed and emerging economies
-
January 13, 2012
No one got all 20 answers right in Managing IP’s quiz of the year’s news. But two entrants shared the prize with 19 correct answers
-
October 17, 2011
India’s Department of Industrial Policy and Promotion has launched a review of the organisational structure of the IP office that could split the patent and trade mark departments and make them autonomous agencies
-
September 22, 2011
Indian generic drug maker Natco has filed a compulsory licence application for the patent covering German pharma company Bayer’s anti-cancer drug Nexavar
-
September 09, 2011
A Supreme Court judge in India has recused himself from hearing a key patent case this week after protests from healthcare activists over his attending and making comments at events sponsored by IP owners